Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-06

Clinical Trial Update: Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia

View source ↗

Summary

The update reports the outcome data from a study evaluating botulinum toxin treatment for oromandibular dystonia. It summarizes the effectiveness and safety fin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Dystonia; Orofacial | Status: COMPLETED